- Record: found
- Abstract: found
- Article: found
The Histochemistry of Prefascial Lymph Vessels in Recurrent Erysipelas
Read this article at
Abstract
For histochemical examination, excisions were taken from the prefascial lymph vessels of the dorsum of the foot in the case of 54 patients with recurrent erysipelas immediately before lymphangiography. The results obtained were compared with the data of a simultaneous histological study. In the course of the studies, the lymph vessel adenosine triphosphatase, leucine aminopeptidase, succinic dehydrogenase, nicotinic acid adenine dinucleotide(-phosρhate) diaphorase, glutamate dehydrogenase and Na- dl- α-glycerophosphate dehydrogenase activity were considered. In the inflammatory lymph vessel processes (thrombolymphangitis obliterans, endolymphangitis proliferans, perilymphangitis chronica, etc.), the activity of adenosine triphosphatase and mitochondrial (oxidative) enzymes was observed to be increased, while in lymphangiopathia obliterans of a degenerative nature they were found to be decreased. It is believed that in the processes accompanied by lumen narrowing, the infiltration of the vessel wall due to inflammatory tissue leads to the stiffening of the vessel wall, the discontinuing of its rhythmic movement, the development of edema in the distal part of the limb, and the further degeneration of the vessel wall.
Related collections
Author and article information
Journal
Affiliations
Article
157967 Angiologica 1973;10:142–151Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.